Effects of age and hypertension on cardiac responses to the alpha(1)-agonist phenylephrine in humans

Citation
M. White et al., Effects of age and hypertension on cardiac responses to the alpha(1)-agonist phenylephrine in humans, AM J HYPERT, 12(2), 1999, pp. 151-158
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
AMERICAN JOURNAL OF HYPERTENSION
ISSN journal
08957061 → ACNP
Volume
12
Issue
2
Year of publication
1999
Part
1
Pages
151 - 158
Database
ISI
SICI code
0895-7061(199902)12:2<151:EOAAHO>2.0.ZU;2-1
Abstract
Both aging and hypertension decrease the responsiveness of several receptor systems. The purpose of this study was to investigate the effect of aging versus hypertension on the blood pressure (BP), heart rate, and left ventri cular (LV) responses to the alpha(1)-agonist phenylephrine in humans. Fourt een young (age, 21-40 years; range, 30 +/- 1 years; mean +/- SEM), and 18 o lder (age, 50-73 years; range, 60 +/- 1 years) healthy volunteers, as well as 10 young (age, 30-39 years; range, 36 +/- 1 years) and 15 older (age, 50 - 64 years; range, 58 +/- 1 years) hypertensive subjects were studied. Phen ylephrine was administered at four incremental rates for 8 min each. Cardia c responses were assessed by echocardiography. Phenylephrine caused twofold larger increases in systolic BP in young and older hypertensives and older normotensives, compared with young normotensives, but similar decreases in heart rate in all four groups. Younger normotensive subjects exhibited the largest decreases in stroke volume index, ejection fraction, and cardiac i ndex in response to phenylephrine, despite similar increases in end-systoli c stress for all groups. There is an age- and hypertension-related decrease in reflex vagal restraint in response to a,adrenoceptor stimulation in hum ans, which leads to significant attenuation of the decrease in heart rate a s well as in LV function in response to a presser stimulus, and presumably therefore to enhanced systolic BP responses relative to young normotensive subjects. Am J Hypertens 1999; 12:151-158 (C) 1999 American Journal of Hype rtension, Ltd.